|
1
|
Machnik A, Neuhofer W, Jantsch J, Dahlmann
A, Tammela T, Machura K, Park JK, Beck FX, Müller DN, Derer W, et
al: Macrophages regulate salt-dependent volume and blood pressure
by a vascular endothelial growth factor-C-dependent buffering
mechanism. Nat Med. 15:545–552. 2009.PubMed/NCBI View
Article : Google Scholar
|
|
2
|
Wheeler-Jones C, Abu-Ghazaleh R, Cospedal
R, Houliston RA, Martin J and Zachary I: Vascular endothelial
growth factor stimulates prostacyclin production and activation of
cytosolic phospholipase A2 in endothelial cells via p42/p44
mitogen-activated protein kinase. FEBS Lett. 420:28–32.
1997.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ferrara N: Vascular endothelial growth
factor. Eur J Cancer. 32A:2413–2422. 1996.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Roskoski R Jr: VEGF receptor
protein-tyrosine kinases: Structure and regulation. Biochem Biophys
Res Commun. 375:287–291. 2008.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Rahimi N, Golde TE and Meyer RD:
Identification of ligand-induced proteolytic cleavage and
ectodomain shedding of VEGFR-1/FLT1 in leukemic cancer cells.
Cancer Res. 69:2607–2614. 2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ebos JM, Bocci G, Man S, Thorpe PE,
Hicklin DJ, Zhou D, Jia X and Kerbel RS: A naturally occurring
soluble form of vascular endothelial growth factor receptor 2
detected in mouse and human plasma. Mol Cancer Res. 2:315–326.
2004.PubMed/NCBI
|
|
7
|
Koga K, Osuga Y, Yoshino O, Hirota Y,
Ruimeng X, Hirata T, Takeda S, Yano T, Tsutsumi O and Taketani Y:
Elevated serum soluble vascular endothelial growth factor receptor
1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol
Metab. 88:2348–2351. 2003.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Rath G and Tripathi R: VEGF and its
soluble receptor VEGFR-2 in hypertensive disorders during
pregnancy: The Indian scenario. J Hum Hypertens. 26:196–204.
2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zachary I, Mathur A, Yla-Herttuala S and
Martin J: Vascular protection: A novel nonangiogenic cardiovascular
role for vascular endothelial growth factor. Arterioscler Thromb
Vasc Biol. 20:1512–1520. 2000.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Servos S, Zachary I and Martin JF: VEGF
modulates NO production: The basis of a cytoprotective effect?
Cardiovasc Res. 41:509–510. 1999.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Yap RW, Shidoji Y, Hon WM and Masaki M:
Association and interaction between dietary pattern and VEGF
receptor-2 (VEGFR2) gene polymorphisms on blood lipids in Chinese
Malaysian and Japanese adults. Asia Pac J Clin Nutr. 21:302–311.
2012.PubMed/NCBI
|
|
12
|
Kubisz P, Chudý P, Stasko J, Galajda P,
Hollý P, Vysehradský R and Mokán M: Circulating vascular
endothelial growth factor in the normo- and/or microalbuminuric
patients with type 2 diabetes mellitus. Acta Diabetol. 47:119–124.
2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Coulon S, Francque S, Colle I, Verrijken
A, Blomme B, Heindryckx F, De Munter S, Prawitt J, Caron S, Staels
B, et al: Evaluation of inflammatory and angiogenic factors in
patients with non-alcoholic fatty liver disease. Cytokine.
59:442–449. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Jaroszewicz J, Januszkiewicz M, Flisiak R,
Rogalska M, Kalinowska A and Wierzbicka I: Circulating vascular
endothelial growth factor and its soluble receptors in patients
with liver cirrhosis: Possible association with hepatic function
impairment. Cytokine. 44:14–17. 2008.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kim BM, Lee DH, Choi HJ, Lee KH, Kang SJ,
Joe YA, Hong YK and Hong SH: The recombinant kringle domain of
urokinase plasminogen activator inhibits VEGF165-induced
angiogenesis of HUVECs by suppressing VEGFR2 dimerization and
subsequent signal transduction. IUBMB Life. 64:259–265.
2012.PubMed/NCBI View
Article : Google Scholar
|
|
16
|
Noghero A, Perino A, Seano G, Saglio E, Lo
Sasso G, Veglio F, Primo L, Hirsch E, Bussolino F and Morello F:
Liver X receptor activation reduces angiogenesis by impairing lipid
raft localization and signaling of vascular endothelial growth
factor receptor-2. Arterioscler Thromb Vasc Biol. 32:2280–2288.
2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Bodzioch M, Orsó E, Klucken J, Langmann T,
Böttcher A, Diederich W, Drobnik W, Barlage S, Büchler C,
Porsch-Ozcürümez M, et al: The gene encoding ATP-binding cassette
transporter 1 is mutated in Tangier disease. Nat Genet. 22:347–351.
1999.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Fang L, Choi SH, Baek JS, Liu C, Almazan
F, Ulrich F, Wiesner P, Taleb A, Deer E, Pattison J, et al: Control
of angiogenesis by AIBP-mediated cholesterol efflux. Nature.
498:118–122. 2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhang M and Jiang L: Oxidized low-density
lipoprotein decreases VEGFR2 expression in HUVECs and impairs
angiogenesis. Exp Ther Med. 12:3742–3748. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Liu H, Yu S, Zhang H and Xu J:
Angiogenesis impairment in diabetes: Role of methylglyoxal-induced
receptor for advanced glycation endproducts, autophagy and vascular
endothelial growth factor receptor 2. PLoS One.
7(e46720)2012.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Roy H, Bhardwaj S, Babu M, Kokina I,
Uotila S, Ahtialansaari T, Laitinen T, Hakumaki J, Laakso M, Herzig
KH, et al: VEGF-A, VEGF-D, VEGF receptor-1, VEGF receptor-2,
NF-kappaB, and RAGE in atherosclerotic lesions of diabetic Watanabe
heritable hyperlipidemic rabbits. FASEB J. 20:2159–2161.
2006.PubMed/NCBI View Article : Google Scholar
|
|
22
|
World Medical Association Declaration of
Helsinki. Ethical principles for medical research involving human
subjects. JAMA. 310:2191–2194. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Update of the National Kidney
Foundation-Kidney Disease Outcomes Quality Initiative Clinical
Practice Guideline for Hemodialysis Adequacy. 2015. https://www.ajkd.org/article/S0272-6386(15)01019-7/fulltext.
|
|
24
|
Kouw PM, Olthof CG, ter Wee PM, Oe LP,
Donker AJ, Schneider H and de Vries PM: Assessment of post-dialysis
dry weight: An application of the conductivity measurement method.
Kidney Int. 41:440–444. 1992.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Hamaguchi M, Kojima T, Itoh Y, Harano Y,
Fujii K, Nakajima T, Kato T, Takeda N, Okuda J, Ida K, et al: The
severity of ultrasonographic findings in nonalcoholic fatty liver
disease reflects the metabolic syndrome and visceral fat
accumulation. Am J Gastroenterol. 102:2708–2715. 2007.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Reiner Z, Catapano AL, De Backer G, Graham
I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ,
Durrington P, et al: European Association for Cardiovascular
Prevention and Rehabilitation; ESC Committee for Practice
Guidelines (CPG) 2008-2010 and 2010-2012 Committees. ESC/EAS
Guidelines for the management of dyslipidaemias: The Task Force for
the management of dyslipidaemias of the European Society of
Cardiology (ESC) and the European Atherosclerosis Society (EAS).
Eur Heart J. 32:1769–1818. 2011.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kidney Disease Outcomes Quality Initiative
(K/DOQI) Group. K/DOQI clinical practice guidelines for management
of dyslipidemias in patients with kidney disease. Am J Kidney Dis.
41 (Suppl 3): I-IV:S1–S91. 2003.PubMed/NCBI
|
|
28
|
Hanak V, Munoz J, Teague J Jr, Stanley A
Jr and Bittner V: Accuracy of the triglyceride to high-density
lipoprotein cholesterol ratio for prediction of the low-density
lipoprotein phenotype B. Am J Cardiol. 94:219–222. 2004.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Friedewald WT, Levy RI and Fredrickson DS:
Estimation of the concentration of low-density lipoprotein
cholesterol in plasma, without use of the preparative
ultracentrifuge. Clin Chem. 18:499–502. 1972.PubMed/NCBI
|
|
30
|
Matthews DR, Hosker JP, Rudenski AS,
Naylor BA, Treacher DF and Turner RC: Homeostasis model assessment:
Insulin resistance and beta-cell function from fasting plasma
glucose and insulin concentrations in man. Diabetologia.
28:412–419. 1985.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Alberti G, Shaw J and Zimmet P: A new IDF
worldwide definition of the metabolic syndrome: The rationale and
the results. Diabetes Voice. 50:31–33. 2005.PubMed/NCBI
|
|
32
|
Sepe V, Libetta C, Rossi N, Guidetti C and
Dal Canton A: Inverse association between homocysteine and vascular
endothelial growth factor receptor 2 serum levels in hemodialyzed
and kidney transplanted patients. Kidney Int.
64(1922)2003.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Karg E, Papp F, Tassi N, Janáky T,
Wittmann G and Túri S: Enhanced methylglyoxal formation in the
erythrocytes of hemodialyzed patients. Metabolism. 58:976–982.
2009.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Stinghen AE, Massy ZA, Vlassara H, Striker
GE and Boullier A: Uremic toxicity of advanced glycation end
products in CKD. J Am Soc Nephrol. 27:354–370. 2016.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Schmidt S, Westhoff TH, Krauser P, Zidek W
and van der Giet M: The uraemic toxin phenylacetic acid increases
the formation of reactive oxygen species in vascular smooth muscle
cells. Nephrol Dial Transplant. 23:65–71. 2008.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Mahdy RA, Nada WM, Hadhoud KM and
El-Tarhony SA: The role of vascular endothelial growth factor in
the progression of diabetic vascular complications. Eye (Lond).
24:1576–1584. 2010.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Jesmin S, Akter S, Rahman MM, Islam MM,
Islam AM, Sultana SN, Mowa CN, Yamaguchi N, Okazaki O, Satoru K, et
al: Disruption of components of vascular endothelial growth factor
angiogenic signalling system in metabolic syndrome. Findings from a
study conducted in rural Bangladeshi women. Thromb Haemost.
109:696–705. 2013.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Wada H, Satoh N, Kitaoka S, Ono K,
Morimoto T, Kawamura T, Nakano T, Fujita M, Kita T, Shimatsu A, et
al: Soluble VEGF receptor-2 is increased in sera of subjects with
metabolic syndrome in association with insulin resistance.
Atherosclerosis. 208:512–517. 2010.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Lai YC, Cheng BC, Hwang JC, Lee YT, Chiu
CH, Kuo LC and Chen JB: Association of fatty liver disease with
nonfatal cardiovascular events in patients undergoing maintenance
hemodialysis. Nephron Clin Pract. 124:218–223. 2013.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Capone D, Vinciguerra M, Ragosta A, Citro
V and Tarantino G: Troponin levels relate to CRP concentrations in
patients with NAFLD on maintenance Haemodialysis: A retrospective
study. Adv Ther. 37:3337–3347. 2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Wu PJ, Chen JB, Lee WC, Ng HY, Lien SC,
Tsai PY, Wu CH, Lee CT and Chiou TT: Oxidative stress and
nonalcoholic fatty liver disease in hemodialysis patients. BioMed
Res Int. 2018(3961748)2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Vaziri ND, Yuan J, Ni Z, Nicholas SB and
Norris KC: Lipoprotein lipase deficiency in chronic kidney disease
is accompanied by down-regulation of endothelial GPIHBP1
expression. Clin Exp Nephrol. 16:238–243. 2012.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Chiu AP, Wan A, Lal N, Zhang D, Wang F,
Vlodavsky I, Hussein B and Rodrigues B: Cardiomyocyte VEGF
regulates endothelial cell GPIHBP1 to relocate lipoprotein lipase
to the coronary lumen during diabetes mellitus. Arterioscler Thromb
Vasc Biol. 36:145–155. 2016.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Jin F, Hagemann N, Brockmeier U, Schäfer
ST, Zechariah A and Hermann DM: LDL attenuates VEGF-induced
angiogenesis via mechanisms involving VEGFR2 internalization and
degradation following endosome-trans-Golgi network trafficking.
Angiogenesis. 16:625–637. 2013.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Rodríguez JA, Nespereira B, Pérez-Ilzarbe
M, Eguinoa E and Páramo JA: Vitamins C and E prevent endothelial
VEGF and VEGFR-2 overexpression induced by porcine
hypercholesterolemic LDL. Cardiovasc Res. 65:665–673.
2005.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Zimman A, Mouillesseaux KP, Le T, Gharavi
NM, Ryvkin A, Graeber TG, Chen TT, Watson AD and Berliner JA:
Vascular endothelial growth factor receptor 2 plays a role in the
activation of aortic endothelial cells by oxidized phospholipids.
Arterioscler Thromb Vasc Biol. 27:332–338. 2007.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Ylä-Herttuala S, Palinski W, Rosenfeld ME,
Parthasarathy S, Carew TE, Butler S, Witztum JL and Steinberg D:
Evidence for the presence of oxidatively modified low density
lipoprotein in atherosclerotic lesions of rabbit and man. J Clin
Invest. 84:1086–1095. 1989.PubMed/NCBI View Article : Google Scholar
|
|
48
|
van Merode T, Hick P, Hoeks PG and Reneman
RS: Serum HDL/total cholesterol ratio and blood pressure in
asymptomatic atherosclerotic lesions of the cervical carotid
arteries in men. Stroke. 16:34–38. 1985.PubMed/NCBI View Article : Google Scholar
|
